Books on the topic 'BRCA1'

To see the other types of publications on this topic, follow the link: BRCA1.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'BRCA1.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Winter, Sherry Lynn. Identification of BRCA1 interacting proteins. Ottawa: National Library of Canada, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Canadian Coordinating Office for Health Technology Assessment., ed. A clinical systematic review of BRCA1 and BRCA2 genetic testing for breast and ovarian cancers. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

National Institutes of Health (U.S.). Clinical Center and National Institutes of Health (U.S.). Office of Clinical Center Communications, eds. Answers to your questions: Testing for BRCA1. [Bethesda, Md.?]: The Warren Grant Magnuson Clinical Center, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

National Institutes of Health (U.S.). Clinical Center. and National Institutes of Health (U.S.). Office of Clinical Center Communications., eds. Answers to your questions: Testing for BRCA1. [Bethesda, Md.?]: The Warren Grant Magnuson Clinical Center, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lynda, McGahan, and Canadian Coordinating Office for Health Technology Assessment, eds. BRCA1 and BRCA2 predictive genetic testing for breast and ovarian cancers: A systematic review of clinical evidence. Ottawa: CCOHTA, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Reczek, Colleen Renee. The Role of CtIP in BRCA1-Mediated Tumor Suppression. [New York, N.Y.?]: [publisher not identified], 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Reid, Latarsha. Analysis of The RING Domain And BRCT Repeats of BRCA1. [New York, N.Y.?]: [publisher not identified], 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gabriel, Sarah. Eating pomegranates: A memoir of mothers, daughters, and the BRCA gene. New York: Scribner, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gabriel, Sarah. Eating pomegranates: A memoir of mothers, daughters and genes. Rearsby: Clipper Large Print, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

H, Lu Karen, ed. Hereditary gynecologic cancer: Risk, prevention, and management. New York: Informa Healthcare, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Gabriel, Sarah. Eating pomegranates: A memoir of mothers, daughters, and the BRCA gene. New York: Scribner, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

B. Chagpar, Anees, ed. Managing BRCA Mutation Carriers. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-59198-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Gerhardus, Ansgar, Henriette Schleberger, Brigitte Schlegelberger, and Friedrich Wilhelm Schwartz, eds. BRCA — Erblicher Brust- und Eierstockkrebs. Berlin/Heidelberg: Springer-Verlag, 2005. http://dx.doi.org/10.1007/b137779.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Herrlinger, Karolina Anna. Die Patentierung von Krankheitsgenen: Dargestellt am Beispiel der Patentierung der Brustkrebsgene BRCA 1 und BRCA 2. Köln: Heymanns, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

1966-, Gordon Ora Karp, ed. Positive results: Making the best decisions when you're at high risk for breast or ovarian cancer. Amherst, N.Y: Prometheus Books, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Blood matters: A journey along the genetic frontier. London: Granta, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

author, Gosline Diana, and Smith Diana author, eds. Deleterious: A Mutant Gene Zine. Portland, OR: the authors, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Ionescu, Daniela. Protein-protein interactions between the breast cancer susceptibility gene product BRCA2 and replication protein A. Ottawa: National Library of Canada, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Genetic testing for breast and ovarian cancer risk: It's your choice. 2nd ed. Bethesda, Md.]: U.S. Dept. of Health and Human Services, National Institutes of Health, National Cancer Institute, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Legacy for Donna: A palliative death full of blessings : a plea for preventive health genealogies. Durham, CT: Eloquent Books, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

From the feet up. 2nd ed. North Sydney, N.S.W: Harlequin Mira, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Drugs for HER2-positive breast cancer. Basel: Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

service), SpringerLink (Online, ed. The Role of Genetics in Breast and Reproductive Cancers. New York, NY: Springer Science+Business Media, LLC, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

BRCA1 and BRCA2 Mutations - Diagnostic and Therapeutic Implications [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.100842.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Mark, Wen-Ying. Domain characterization of human BRCA1. 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Mark, Wen-Ying. Domain characterization of human BRCA1. 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Firth, Helen V., Jane A. Hurst, and Judith G. Hall. Cancer. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780192628961.003.0156.

Full text
Abstract:
BRCA1 and BRCA2 426Breast cancer 430Cancer surveillance methods 434Colorectal cancer (CRC) 436Confirmation of diagnosis of cancer 440Cowden syndrome (CS) 442Familial adenomatous polyposis (FAP) 444Gastric cancer 450Gorlin syndrome 452Hereditary nonpolyposis colorectal cancer (HNPCC) 454Juvenile polyposis syndrome (JPS) ...
APA, Harvard, Vancouver, ISO, and other styles
28

Gibson, Lianne Mary. Functional interactions of tumor suppressors Brca1 and Mus81. 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Kwon, Rachel J. Breast Cancer after Prophylactic Bilateral Mastectomy in Patients with BRCA Mutation. Edited by Patrick Borgen and Miguel A. Burch. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199384075.003.0024.

Full text
Abstract:
This chapter provides a summary of a landmark study in breast surgical oncology. Does prophylactic bilateral mastectomy reduce the incidence of breast cancer in patients with BRCA1 or BRCA2 mutation? Starting with that question, it describes the basics of the study, including funding, year study began, year study was published, study location, who was studied, who was excluded, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. The chapter briefly reviews other relevant studies and information, gives a summary and discusses implications, and concludes with a relevant clinical case involving the possibility of prophylactic bilateral mastectomy for breast cancer.
APA, Harvard, Vancouver, ISO, and other styles
30

Ali-Fehmi, Rouba, and Eman Abdulfatah. Biological Aspects and Clinical Applications of Serum Biomarkers in Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0002.

Full text
Abstract:
Ovarian cancer, the most aggressive gynecological malignancy, presents at advanced stages with metastatic disease. Diagnosis at an early stage is the most important determinant of survival; however, the majority of patients are asymptomatic at early stages and the current diagnostic tools used in clinics show limited success in early detection and hence the need for new diagnostic biomarkers. With the advance of techniques in genomic and proteomics, numerous biomarkers are emerging which may serve as a platform for early detection of ovarian cancer. These include gene-, protein-, miRNAs, and metabolite- based biomarkers. Examples of gene-based biomarkers include HE4, FLOR1, p16INK4a, BRCA1, BRCA2, MLH1, and MSH2. Protein- based biomarkers include leptin, prolactin, osteopontin, IGF-II, and MIF. This chapter discusses the serum tumor markers (CA-125) in current use for screening, diagnosis and monitoring of ovarian cancer as well as the novel biomarkers that are under investigation and validation.
APA, Harvard, Vancouver, ISO, and other styles
31

Lu, Karen H. Hereditary Gynecologic Cancer: Risk, Prevention and Management. Taylor & Francis Group, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Lu, Karen H. Hereditary Gynecologic Cancer: Risk, Prevention and Management. Taylor & Francis Group, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

GIBBON, SAHRA, Jessica Mozersky, Andrea zur Nieden, Galen Joseph, and Sonja Palfner. Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA. Taylor & Francis Group, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA. Taylor & Francis Group, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of Brca. Routledge, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

GIBBON, SAHRA, Jessica Mozersky, Andrea zur Nieden, Galen Joseph, and Sonja Palfner. Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA. Taylor & Francis Group, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Weberpals, Johanne Ingrid. The role of the BRCA1-dependent DNA repair pathway in the pathogenesis of non-hereditary epithelial ovarian cancer. 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Weberpals, Johanne Ingrid. The role of the BRCA1-dependent DNA repair pathway in the pathogenesis of non-hereditary epithelial ovarian cancer. 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Hereditary Gynecologic Cancer: Risk, Prevention and Management. Informa Healthcare, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
40

Pandora's DNA: Tracing the Breast Cancer Genes Through History, Science, and One Family Tree. Chicago Review Press, Incorporated, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

Stark, Lizzie. Pandora's DNA: Tracing the Breast Cancer Genes Through History, Science, and One Family Tree. Chicago Review Press, Incorporated, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

Pandora's DNA: Tracing the breast cancer genes through history, science, and one family tree. Chicago Review Press, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

Stark, Lizzie. Pandora's DNA: Tracing the Breast Cancer Genes Through History, Science, and One Family Tree. Chicago Review Press, Incorporated, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
44

Schleberger, Henriette, Brigitte Schlegelberger, Ansgar Gerhardus, and Friedrich W. Schwartz. BRCA - Erblicher Brust- und Eierstockkrebs: Beratung - Testverfahren - Kosten. Springer London, Limited, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

(Editor), Ansgar Gerhardus, Henriette Schleberger (Editor), Brigitte Schlegelberger (Editor), and Friedrich W. Schwartz (Editor), eds. BRCA - Erblicher Brust- und Eierstockkrebs: Beratung - Testverfahren - Kosten. Springer, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

Gessen, Masha. Blood Matters: From BRCA1 to Designer Babies, How the World and I Found Ourselves in the Future of the Gene. Houghton Mifflin Harcourt Trade & Reference Publishers, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
47

Gessen, Masha. Blood Matters: From BRCA1 to Designer Babies, How the World and I Found Ourselves in the Future of the Gene. Houghton Mifflin Harcourt Trade & Reference Publishers, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
48

Winter, Sherry Lynn. Genetic and functional characterization of the interaction of BRCA1 with the serine/threonine phosphatase, PP1, and the circadian clock proteins, Per1 and Per2. 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
49

Chagpar, Anees B. Managing BRCA Mutation Carriers. Springer, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
50

Chagpar, Anees B. Managing BRCA Mutation Carriers. Springer International Publishing AG, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography